620P MGC018, an anti-B7-H3 antibody-drug conjugate (ADC), in patients with advanced solid tumors: Preliminary results of phase I cohort expansion.
Saved in:
| Title: | 620P MGC018, an anti-B7-H3 antibody-drug conjugate (ADC), in patients with advanced solid tumors: Preliminary results of phase I cohort expansion. |
|---|---|
| Authors: | Shenderov, E.1 (AUTHOR), Mallesara, G.H.G.2 (AUTHOR), Wysocki, P.J.3 (AUTHOR), Xu, W.4 (AUTHOR), Ramlau, R.5 (AUTHOR), Weickhardt, A.J.6 (AUTHOR), Zolnierek, J.7 (AUTHOR), Spira, A.8 (AUTHOR), Joshua, A.M.9 (AUTHOR), Powderly, J.10 (AUTHOR), Antonarakis, E.S.11 (AUTHOR), Jang, S.12 (AUTHOR), Aragon-Ching, J.13 (AUTHOR), Shen, J.14 (AUTHOR), Paller, C.15 (AUTHOR), Vogelzang, N.J.16 (AUTHOR), Leu, K.17 (AUTHOR), Cortés, J.18 (AUTHOR), Bohac, C.19 (AUTHOR), Lugowska, I.20 (AUTHOR) |
| Source: | Annals of Oncology. 2021 Supplement 5, Vol. 32, pS657-S659. 3p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
